TerminatedPhase 1NCT01324635

Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

Studying Meningioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Principal Investigator
Wenyin Shi, MD, PhD, MD, PHD
Thomas Jefferson University
Intervention
Panobinostat(drug)
Enrollment
17 enrolled
Eligibility
18 years · All sexes
Timeline
2012 – 2016

Study locations (1)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01324635 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma →

← Back to all trials